Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with KNSA: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
KNSA
Kiniksa Pharmaceuticals International, plc
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
KNSA
Kiniksa Pharmaceuticals International, plc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
LLY
with
KNSA
No shared trading history for LLY and KNSA.
Shared co-movers: not yet measured (KNSA).
LLY, solid
KNSA, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,358.90
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
KNSA
Kiniksa Pharmaceuticals International, plc
Change
93.80
▲
+6.18%
· post 94.50
Closed
Nov 6 '26
Mkt cap
$7.4B
Revenue
$286M
Q3 FY26
Revenue
$678M
FY25
vs
Compare
Closed
Nov 6 '26
LLY
ELI Lilly & Co
vs
KNSA
Kiniksa Pharmaceuticals International, plc
1,360.90
▼
−0.28%
post 1,358.90
Price
93.80
▲
+6.18%
post 94.50
$1.2T
Mkt cap
$7.4B
Q3 FY26
$24.4B
Revenue
$286M
Q3 FY26
FY25
$65.2B
Revenue
$678M
FY25
Change
Change
LLY
1,360.90
▼
−0.28%
vs
KNSA
93.80
▲
+6.18%
Closed
Nov 6 '26